Hepatitis D
📧 Sign up to get email alerts when something new happens for Hepatitis D.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
This completed study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) evaluated the response to COV…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide [Phase 2, Phase 3]
Phase 2b/3 trial update evaluating switching to Brelovitug for chronic hepatitis D in participants receiving Bulevirtide; recruitment is ong…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study) [Phase 3]
This entry describes a Phase 3 clinical trial (D-clear) evaluating the efficacy and safety of Libevitug in adults with chronic hepatitis D i…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evaluation of Patients With Liver Disease
This clinical trial is currently recruiting participants to study liver disease and hepatitis conditions under the National Institute of Dia…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection [Phase 3]
A Phase 3 study evaluating Tobevibart in combination with Elebsiran for chronic hepatitis D virus infection, with the trial currently active…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-03-31EMA Authorised: Hepcludex (bulevirtide acetate) — Gilead Sciences Ireland UC
EMA authorised Hepcludex (bulevirtide) by Gilead Sciences Ireland UC for chronic hepatitis D.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide [Phase 3]
This Phase 3 study is evaluating a combination of Tobevibart and Elebsiran in participants with chronic hepatitis D infection not virologica…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2) [Phase 3]
A Phase 3 clinical trial (AZURE-2) comparing Brelovitug (BJT-778) to bulevirtide for chronic hepatitis D infection is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
This clinical trial update describes an oral-periodontal evaluation and assessment of oral fluid biomarkers in patients with chronic hepatit…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Expanded Access for Bulevirtide
Gilead Sciences is offering expanded access to bulevirtide for patients with chronic hepatitis D virus infection.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection [NA]
This clinical trial update from Hannover Medical School discusses finite bulevirtide treatment for hepatitis D. It focuses on identifying bi…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4) [Phase 3]
A Phase 3 study called AZURE-4 is evaluating Brelovitug versus delayed treatment for chronic hepatitis D infection. The trial is currently r…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: ePro Diary - HDV ( MACROLIVER )
The clinical trial 'ePro Diary - HDV (MACROLIVER)' is currently recruiting participants for HDV infection. Sponsor: Fondazione per la Ricerc…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/3 study of BJT-778 versus delayed treatment for chronic hepatitis D infection, with the trial…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
A French research trial aims to assemble a biological collection to develop preclinical translational models for tumors and chronic liver di…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D [Phase 2]
A Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of RBD1016 in participants with chronic hepatitis D is curren…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: 10119473 -VIROMARKERS HDV Biomarkers Study
A clinical trial update for the VIROMARKERS HDV Biomarkers Study (NCT07313358) sponsored by the University of Rome Tor Vergata, investigatin…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection [Phase 2]
This Phase 2 trial compares tobevibart plus elebsiran against bulevirtide in adults with chronic hepatitis D virus infection; the study is c…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment
This clinical trial update characterizes immunological and virological features in chronic HBV-HDV infection. It also assesses responses to …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease
An update on an ongoing clinical trial evaluating a rapid T-cell analysis test in patients with chronic hepatitis B infection and HBV/HDV co…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: "Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.
A recruiting clinical trial in Bergamo, Italy studying referral pathways from screening to care for Hepatitis D.
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D [Phase 3]
A Phase 3 clinical trial evaluating Hepalatide for chronic hepatitis D is not yet recruiting. The trial is sponsored by Shanghai HEP Pharmac…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D [Phase 2]
This entry reports a Phase 2 clinical trial evaluating Hepalatide for injection in patients with chronic hepatitis D, with the study listed …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants [Phase 1]
A Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of ABI-6250 in healthy participants for hepatitis D is reported as…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study of Bulevirtide in Participants With Chronic Hepatitis D Infection
A clinical trial update indicates bulevirtide is being studied for chronic hepatitis D infection, with the study currently active but not re…